Search

Your search keyword '"Morrow A"' showing total 22,066 results

Search Constraints

Start Over You searched for: Author "Morrow A" Remove constraint Author: "Morrow A" Database OpenAIRE Remove constraint Database: OpenAIRE
22,066 results on '"Morrow A"'

Search Results

1. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY)

2. Moderate reliability of the lateral step down test amongst experienced and novice physical therapists

3. Evaluating the Evidence for the Functional Inhibition Account of Alpha-band Oscillations during Preparatory Attention

4. Examination of Morphological and Chemical Properties of Ni-BZY Anodes and their Influence upon Methane Reactivity and Electrochemical Performance of Protonic-Ceramic Fuel Cells

7. Consensus recommendations for the assessment and treatment of perinatal obsessive–compulsive disorder (OCD): A Delphi study

8. Lipid droplets and peroxisomes are co-regulated to drive lifespan extension in response to mono-unsaturated fatty acids

11. Reversion of mutations in a live mycoplasma vaccine alters its metabolism

13. Distributional Impacts of the Canada-US Free Trade Agreement

16. Systemic Gender Inequities in Who Reviews Code

17. Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation

23. Contributions to Nursing Knowledge: A Dialogue With Dr. Rozzano Locsin

24. Anti-Ageism for Gerontologists

29. Timing of Active Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation Therapy

30. Outcomes of Breast Cancer Patients with High Volume of Residual Disease Following Neoadjuvant Chemotherapy

31. Abstract PD10-04: PD10-04 Combination of the next generation oral SERD camizestrant (AZD9833) with CDK4/6 and mTOR/AKT inhibitors delivers robust efficacy in a broad range of ER+ breast tumors

32. Abstract P5-08-09: Does Breast Inflammation Contribute to Lymphedema Risk in Patients Treated with Axillary Lymph Node Dissection?

33. Abstract P3-07-13: The next generation oral selective estrogen receptor degrader (SERD) camizestrant (AZD9833) is active against wild type and mutant estrogen receptor α

34. <scp>Multi‐disciplinary</scp> collaborative consensus guidance statement on the assessment and treatment of p <scp>ostacute</scp> sequelae of <scp>SARS‐CoV</scp> ‐2 infection ( <scp>PASC</scp> ) in children and adolescents

35. Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome: A Secondary Analysis From IMPROVE-IT

39. Validation of an outpatient questionnaire for bronchopulmonary dysplasia control

40. Pharmacological administration of 3α,5α‐THP into the nucleus accumbens core increases 3α,5α‐THP expression and reduces alcohol self‐administration

41. Leveraging Kindness in Canadian Post-Secondary Education: A Conceptual Paper

42. A national case–control study investigating demographic and environmental factors associated with NMOSD

45. Characteristics of men who report symptoms of delayed ejaculation: providing support for empirically derived diagnostic criteria

48. Discovery of a Potent and Orally Bioavailable Zwitterionic Series of Selective Estrogen Receptor Degrader-Antagonists

49. Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study

Catalog

Books, media, physical & digital resources